Skip to content

LLIF Plus Posterior Decompression for Severe Lumbar Spinal Stenosis

A Randomized, Controlled Trial of Lateral Lumbar Interbody Fusion Plus Posterior Decompression or Not for Severe Lumbar Spinal Stenosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04094220
Enrollment
72
Registered
2019-09-18
Start date
2019-08-01
Completion date
2022-12-30
Last updated
2023-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spine Degeneration, Lumbar Spinal Stenosis

Keywords

indirect decompression, lateral interbody fusion, lumbar, direct decompression

Brief summary

Lateral lumbar interbody fusion (LLIF), as a minimally invasive technique, is an indirect decompression technique, and its decompression effect is not as thorough as traditional posterior decompression surgery. For certain patients with severe lumbar stenosis, additional posterior decompression is required. However, whether additional posterior decompression is necessary for these patients is unknown. Radiographic predictors of failed indirect decompression via LLIF is unknown. In current randomized, controlled trial , the investigators compare the clinical outcomes of patients with severe lumbar stenosis who received LLIF plus posterior decompression and those without posterior decompression.

Detailed description

The current randomized controlled trial consists of two groups. Patients included in the study are with Schizas's stenosis grades C. Patients in one group received transpsoas lateral lumbar interbody fusion. Patients in the other group received transpsoas lateral lumbar interbody fusion plus posterior decompression. Patients will be followed for one year. Clinical outcomes of the two groups will be compared. And radiographic predictors of failed indirect decompression via LLIF will be analyzed.

Interventions

LLIF is an indirect decompression technique, and does not directly remove the disc or osteophyte protruding into the spinal canal. Its decompression effect is not as thorough as traditional posterior decompression surgery. Usually, posterior decompression is required for patients who have unsuccessful indirect decompression.

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients included in this study are with degenerative lumbar stenosis and Schizas's stenosis grades C. Patients who suffered from significant lumbar scoliosis, grade 2 spondylolisthesis, lumbar fracture and prior lumbar surgery are excluded from this study.

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Male and female patients who are 50 - 80 years of age. * Patients who present with symptomatic Grade I or II degenerative spondylolisthesis at one or two contiguous lumbar levels between L1 and L5 and who are surgical candidates for interbody lumbar fusion surgery; symptoms should include radiculopathy and/or neurogenic claudication with or without back pain. * Patients who have been unresponsive to at least 6 months of conservative treatments or who exhibit progressive neurological symptoms in the face of conservative treatment. * Patients who understand the conditions of enrollment and are willing to sign an informed consent to participate in the study.

Exclusion criteria

* Patients with lumbar pathologies requiring treatment at more than two levels. * Patients who have had previous lumbar fusion surgery. * Patients with congenital lumbar stenosis. * Patients with radiographic confirmation of Grade IV facet joint disease or degeneration. * Patients with noncontained or extruded herniated nucleus pulposus. * Patients with active local or systemic infection. * Patients with rheumatoid arthritis or other autoimmune disease. * Patients who cannot undergo magnetic resonance imaging (MRI). * Patients who are mentally incompetent. * Patients with BMI over 30kg/m2 or less than 18 kg/m2.

Design outcomes

Primary

MeasureTime frameDescription
Oswestry Disability Index (ODI)Preoperative, 3-month, 12-month,24-month after surgeryThe ODI is an extremely important tool that researchers and disability evaluators use to measure a patient's permanent functional disability

Secondary

MeasureTime frameDescription
Visual Analogue Scale (VAS)Preoperative, 3-month, 12-month,24-month after surgeryThe VAS is a self-report measure of the intensity of pain (score range 0 - 10 ). A higher score indicates greater pain intensity.
Zurich Claudication Questionnaire(ZCQ)Preoperative, 3-month, 12-month,24-month after surgeryThe ZCQ is a disease-specific self-report outcome instrument commonly used in trials to measure treatment outcomes in patients with lumbar spinal stenosis.The result is expressed as a percentage of the maximum possible score (22.22% - 100%). The score increases with worsening disability.The The ZCQ consists of three subscales: symptom severity scale, physical function scale and patient's satisfaction with treatment scale.

Other

MeasureTime frameDescription
The height of the bilateral intervertebral foramenPreoperative,postoperative, 6-month,12-month,24-month after surgeryThe distance of minimum diameter between adjacent pedicles on CT.
Axial central canal areaPreoperative,postoperative,12-month,24-month after surgeryThe area of the spinal central canal with the most stenosis at the level of the intervertebral disc on MRI.
Disc anglePreoperative,postoperative, 6-month,12-month,24-month after surgeryThe angles of the lines parallel to the upper and lower endplates in the intervertebral space.
Midsagittal canal diameterPreoperative,postoperative,12-month,24-month after surgeryThe canal diameter at the midsagittal slice on MRI.
anterior and posterior disc heightPreoperative,postoperative, 6-month,12-month,24-month after surgeryThe disc height at the anterior and posterior rim of the intervertebral disc on X-ray.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026